Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients

Author： Howles C. M.   Saunders H.   Alam V.   Engrand P.    

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.5, 2006-05, pp. : 907-918

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Seminal anti‐Müllerian hormone levels during recombinant human follicle‐stimulating hormone treatment in men with idiopathic infertility undergoing assisted reproduction cycles

By  

ANDROLOGY, Vol. 3, Iss. 5, 2015-09 ,pp. : 843-847

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is there a need for recombinant human luteinizing hormone (lutropin alfa) supplementation in ovarian stimulation for assisted reproduction?

By Nawroth Frank   Ludwig Michael  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 375-384

Future Medicine

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone (follitropin alfa) for ovulation induction in Japanese patients with anti-estrogen-ineffective oligo- or anovulatory infertility: results of a phase II dose-response study

By Taketani Yuji  

Reproductive Medicine and Biology, Vol. 9, Iss. 2, 2010-06 ,pp. : 91-97

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of idiopathic oligozoospermia with recombinant human follicle‐stimulating hormone: a prospective, randomized, double‐blind, placebo‐controlled clinical study in Chinese population

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 6, 2015-12 ,pp. : 866-871

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone (follitropin alfa) versus purified urinary follicle-stimulating hormone in a low-dose step-up regimen to induce ovulation in Japanese women with anti-estrogen-ineffective oligo- or anovulatory infertility: results of a single-blind Phase III study

By Taketani Yuji  

Reproductive Medicine and Biology, Vol. 9, Iss. 2, 2010-06 ,pp. : 99-106

Springer Publishing Company

Access to resources Recommend Favorite